Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
15.04
-0.54 (-3.47%)
Feb 28, 2025, 2:45 PM CST
SHE:300601 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 27, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 16,776 | 30,324 | 27,232 | 67,700 | 119,407 | 56,644 | Upgrade
|
Market Cap Growth | -33.14% | 11.35% | -59.77% | -43.30% | 110.80% | 148.78% | Upgrade
|
Enterprise Value | 18,582 | 31,692 | 28,013 | 65,942 | 118,173 | 56,754 | Upgrade
|
Last Close Price | 15.02 | 26.84 | 30.98 | 59.68 | 105.39 | 52.94 | Upgrade
|
PE Ratio | 32.78 | 35.21 | - | 53.59 | 175.81 | 98.60 | Upgrade
|
Forward PE | 26.72 | 22.39 | 22.73 | 50.97 | 114.36 | 79.66 | Upgrade
|
PS Ratio | 5.57 | 8.72 | 8.62 | 18.54 | 52.81 | 29.15 | Upgrade
|
PB Ratio | 1.73 | 3.18 | 3.03 | 7.39 | 16.00 | 20.57 | Upgrade
|
P/TBV Ratio | 2.36 | 3.33 | 3.16 | 7.68 | 16.66 | 23.19 | Upgrade
|
P/FCF Ratio | 222.86 | 96.37 | - | - | - | 475.70 | Upgrade
|
P/OCF Ratio | 33.97 | 29.35 | 49.90 | 40.97 | 271.47 | 112.01 | Upgrade
|
EV/Sales Ratio | 6.13 | 9.11 | 8.87 | 18.06 | 52.26 | 29.20 | Upgrade
|
EV/EBITDA Ratio | 33.11 | 32.55 | 68.98 | 38.68 | 152.49 | 81.84 | Upgrade
|
EV/EBIT Ratio | 50.21 | 40.72 | 136.56 | 50.71 | 173.26 | 92.97 | Upgrade
|
EV/FCF Ratio | 246.85 | 100.72 | - | - | - | 476.62 | Upgrade
|
Debt / Equity Ratio | 0.22 | 0.26 | 0.25 | 0.30 | 0.01 | 0.09 | Upgrade
|
Debt / EBITDA Ratio | 3.77 | 2.53 | 5.64 | 1.61 | 0.12 | 0.37 | Upgrade
|
Debt / FCF Ratio | 28.12 | 7.83 | - | - | - | 2.15 | Upgrade
|
Asset Turnover | 0.21 | 0.24 | 0.23 | 0.31 | 0.33 | 0.53 | Upgrade
|
Inventory Turnover | 0.75 | 0.87 | 0.87 | 1.54 | 0.74 | 0.83 | Upgrade
|
Quick Ratio | 1.22 | 1.66 | 1.84 | 2.35 | 2.68 | 1.80 | Upgrade
|
Current Ratio | 2.23 | 1.96 | 2.21 | 2.80 | 3.04 | 2.10 | Upgrade
|
Return on Equity (ROE) | 5.34% | 9.30% | -1.46% | 15.19% | 13.29% | 25.05% | Upgrade
|
Return on Assets (ROA) | 1.58% | 3.37% | 0.92% | 6.85% | 6.30% | 10.47% | Upgrade
|
Return on Capital (ROIC) | 1.94% | 4.18% | 1.11% | 8.35% | 8.07% | 14.38% | Upgrade
|
Return on Capital Employed (ROCE) | 3.11% | 6.31% | 1.79% | 11.28% | 8.71% | 19.81% | Upgrade
|
Earnings Yield | 3.07% | 2.84% | -0.49% | 1.87% | 0.57% | 1.01% | Upgrade
|
FCF Yield | 0.45% | 1.04% | -2.81% | -1.31% | -0.66% | 0.21% | Upgrade
|
Dividend Yield | 2.57% | 1.42% | - | 1.20% | 0.18% | - | Upgrade
|
Payout Ratio | 89.49% | 27.54% | - | 17.45% | 30.53% | 31.00% | Upgrade
|
Buyback Yield / Dilution | 14.89% | -1.15% | 0.43% | -3.24% | -5.34% | -2.56% | Upgrade
|
Total Shareholder Return | 17.46% | 0.27% | 0.43% | -2.03% | -5.16% | -2.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.